140 related articles for article (PubMed ID: 18471896)
21. Mutations in feline immunodeficiency (FIV) virus envelope gene V3-V5 regions in FIV-infected cats.
Motokawa K; Hohdatsu T; Imori A; Arai S; Koyama H
Vet Microbiol; 2005 Mar; 106(1-2):33-40. PubMed ID: 15737471
[TBL] [Abstract][Full Text] [Related]
22. CD8+ T cells from feline immunodeficiency virus (FIV) infected cats suppress exogenous FIV replication of their peripheral blood mononuclear cells in vitro.
Hohdatsu T; Sasagawa T; Yamazaki A; Motokawa K; Kusuhara H; Kaneshima T; Koyama H
Arch Virol; 2002 Aug; 147(8):1517-29. PubMed ID: 12181672
[TBL] [Abstract][Full Text] [Related]
23. Virulence differences between two field isolates of feline immunodeficiency virus (FIV-APetaluma and FIV-CPGammar) in young adult specific pathogen free cats.
Pedersen NC; Leutenegger CM; Woo J; Higgins J
Vet Immunol Immunopathol; 2001 May; 79(1-2):53-67. PubMed ID: 11356250
[TBL] [Abstract][Full Text] [Related]
24. Partial protection by vaccination with recombinant feline immunodeficiency virus surface glycoproteins.
Leutenegger CM; Hofmann-Lehmann R; Holznagel E; Cuisinier AM; Wolfensberger C; Duquesne V; Cronier J; Allenspach K; Aubert A; Ossent P; Lutz H
AIDS Res Hum Retroviruses; 1998 Feb; 14(3):275-83. PubMed ID: 9491919
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of feline immunodeficiency virus ORF-A mutants as candidate attenuated vaccine.
Pistello M; Bonci F; Isola P; Mazzetti P; Merico A; Zaccaro L; Matteucci D; Bendinelli M
Virology; 2005 Feb; 332(2):676-90. PubMed ID: 15680433
[TBL] [Abstract][Full Text] [Related]
26. Immunization of cats against feline immunodeficiency virus (FIV) infection by using minimalistic immunogenic defined gene expression vector vaccines expressing FIV gp140 alone or with feline interleukin-12 (IL-12), IL-16, or a CpG motif.
Leutenegger CM; Boretti FS; Mislin CN; Flynn JN; Schroff M; Habel A; Junghans C; Koenig-Merediz SA; Sigrist B; Aubert A; Pedersen NC; Wittig B; Lutz H
J Virol; 2000 Nov; 74(22):10447-57. PubMed ID: 11044089
[TBL] [Abstract][Full Text] [Related]
27. [T-helper and T-suppressor lymphocyte subpopulations in the peripheral blood of spontaneously FIV-positive cats].
Hoffmann-Fezer G; Thum I; Herbold M; Ackley C; Mysliwietz J; Hartmann K; Kraft W
Tierarztl Prax; 1991 Dec; 19(6):682-6. PubMed ID: 1665602
[TBL] [Abstract][Full Text] [Related]
28. Puma lentivirus is controlled in domestic cats after mucosal exposure in the absence of conventional indicators of immunity.
Terwee JA; Yactor JK; Sondgeroth KS; Vandewoude S
J Virol; 2005 Mar; 79(5):2797-806. PubMed ID: 15708998
[TBL] [Abstract][Full Text] [Related]
29. Persistent upregulation of MHC class II antigen expression on T-lymphocytes from cats experimentally infected with feline immunodeficiency virus.
Rideout BA; Moore PF; Pedersen NC
Vet Immunol Immunopathol; 1992 Dec; 35(1-2):71-81. PubMed ID: 1363010
[TBL] [Abstract][Full Text] [Related]
30. Toward a detailed characterization of feline immunodeficiency virus-specific T cell immune responses and mediated immune disorders.
Paillot R; Richard S; Bloas F; Piras F; Poulet H; Brunet S; Andreoni C; Juillard V
Vet Immunol Immunopathol; 2005 Jun; 106(1-2):1-14. PubMed ID: 15910988
[TBL] [Abstract][Full Text] [Related]
31. B7+CTLA4+ T cells engage in T-T cell interactions that mediate apoptosis: a model for lentivirus-induced T cell depletion.
Vahlenkamp TW; Bull ME; Dow JL; Collisson EW; Winslow BJ; Phadke AP; Tompkins WA; Tompkins MB
Vet Immunol Immunopathol; 2004 Apr; 98(3-4):203-14. PubMed ID: 15010229
[TBL] [Abstract][Full Text] [Related]
32. Dissection of seroreactivity against the tryptophan-rich motif of the feline immunodeficiency virus transmembrane glycoprotein.
Freer G; Giannecchini S; Tissot A; Bachmann MF; Rovero P; Serres PF; Bendinelli M
Virology; 2004 May; 322(2):360-9. PubMed ID: 15110533
[TBL] [Abstract][Full Text] [Related]
33. HIV-1 p24 vaccine protects cats against feline immunodeficiency virus infection.
Coleman JK; Pu R; Martin M; Sato E; Yamamoto JK
AIDS; 2005 Sep; 19(14):1457-66. PubMed ID: 16135898
[TBL] [Abstract][Full Text] [Related]
34. Analysis of leucocytes and lymphocyte subsets in cats with naturally-occurring cryptococcosis but differing feline immunodeficiency virus status.
Walker C; Malik R; Canfield PJ
Aust Vet J; 1995 Mar; 72(3):93-7. PubMed ID: 7611989
[TBL] [Abstract][Full Text] [Related]
35. Tissue dynamics of CD8 lymphocytes that suppress viral replication in cats infected neonatally with feline immunodeficiency virus.
Crawford PC; Papadi GP; Levy JK; Benson NA; Mergia A; Johnson CM
J Infect Dis; 2001 Sep; 184(6):671-81. PubMed ID: 11517427
[TBL] [Abstract][Full Text] [Related]
36. Use of flow cytometry and monochlorobimane to quantitate intracellular glutathione concentrations in feline leukocytes.
Webb C; Bedwell C; Guth A; Avery P; Dow S
Vet Immunol Immunopathol; 2006 Aug; 112(3-4):129-40. PubMed ID: 16730073
[TBL] [Abstract][Full Text] [Related]
37. Mucosal infection and vaccination against feline immunodeficiency virus.
Stokes CR; Finerty S; Gruffydd-Jones TJ; Sturgess CP; Harbour DA
J Biotechnol; 1999 Aug; 73(2-3):213-21. PubMed ID: 10486930
[TBL] [Abstract][Full Text] [Related]
38. Expression of apoptosis-related gene mRNAs in feline T-cells infected with feline immunodeficiency virus (FIV).
Yamazaki J; Hasebe N; Nagafuchi S; Baba K; Tsujimoto H; Kano R; Hasegawa A
Vet Microbiol; 2004 Jun; 101(1):1-8. PubMed ID: 15201028
[TBL] [Abstract][Full Text] [Related]
39. Salmonella typhimurium aroA recombinants and immune-stimulating complexes as vaccine candidates for feline immunodeficiency virus.
Tijhaar EJ; Huisman W; Huisman RC; Siebelink KH; Karlas JA; de Ronde A; van Herwijnen R; Mooi FR; Osterhaus AD
J Gen Virol; 1997 Dec; 78 ( Pt 12)():3265-75. PubMed ID: 9400977
[TBL] [Abstract][Full Text] [Related]
40. Feline CD8+ cells induced with FIV infected, irradiated T cells produce multiple anti-FIV factors.
Li Z; Phadke A; Weaver EA; Ball JM; Collisson EW
Dev Comp Immunol; 2005; 29(9):809-24. PubMed ID: 15936436
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
